GINFAR
Pharmacology of Inflammation
Publications (7)
filter_list
Dermatology
2024
-
Adenosine A2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasia
Biomedicine and Pharmacotherapy, Vol. 173
-
Antioxidant treatments in patients with oral submucous fibrosis: A systematic review
Journal of Oral Pathology and Medicine, Vol. 53, Núm. 1, pp. 31-41
-
Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model
Drug Delivery and Translational Research, Vol. 14, Núm. 12, pp. 3404-3421
2021
-
Cyanocobalamin ultraflexible lipid vesicles: Characterization and in vitro evaluation of drug-skin depth profiles
Pharmaceutics, Vol. 13, Núm. 3
2020
-
Improved effectiveness from individualized dosing of self-administered biologics for the treatment of moderate-to-severe psoriasis: a 5-year retrospective chart review from a Spanish University Hospital
Journal of Dermatological Treatment, Vol. 31, Núm. 4, pp. 370-377
2018
-
Topical application of glycolipids from isochrysis galbana prevents epidermal hyperplasia in mice
Marine Drugs, Vol. 16, Núm. 1
2014
-
Topical application of the adenosine A2A receptor agonist CGS-21680 prevents phorbol-induced epidermal hyperplasia and inflammation in mice
Experimental Dermatology, Vol. 23, Núm. 8, pp. 555-560